According to a new report released by Express Scripts, the stress associated with providing unpaid care for a sick or disabled adult can create additional detrimental effects on the caregiver's health, leading to a 29% greater use of anti-anxiety medications compared with non-caregivers.
This year, generic drugs account for 83% of all drugs dispensed in the United States, and that figure is set to get even larger over the next few years. That was among the takeaways from IMS Health VP industry relations Doug Long’s presentation Sunday morning.
Meijer announced that it is expanding its mPerks digital coupon program to include pharmacy purchases, allowing customers to personalize their savings and earn rewards in the areas they shop the most whenever they fill a prescription.
Teva Pharmaceutical and Perrigo Co. announced the launch of the generic equivalent to Temodar (temozolomide). Teva will manufacture, market and distribute the product in the United States, and both companies will equally share in the cost and profitability of the product in the country.
Perrigo Co. announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug applications for fluocinolone acetonide scalp oil, 0.01%, the generic equivalent to Derma-Smoothe/FS Scalp Oil, and fluocinolone acetonide topical oil, 0.01%, the generic equivalent to Derma-Smoothe/FS Body Oil.
VoicePort announced the launch of its Medication Synchronization automated solution with two U. S. pharmacy chain clients and are in final stage negotiations with several others in support of helping pharmacies deliver increased patient health-and-wellness.